| Company Name: |
guoyungurui
|
| Tel: |
18162595016 |
| Email: |
3287908757@qq.com |
| Products Intro: |
Cas:12629-01-5
ProductName:Somatropin (5.64 USP Somatropin Units/vial) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED)
Purity: 95%+HPLC | Package: 10mg;25mg;50mg;100mg;200mg
|
| Company Name: |
Riedel-de Haen AG
|
| Tel: |
800 558-9160 |
| Email: |
|
| Products Intro: |
Cas:12629-01-5
ProductName:Somatropin
Brand:Sigma-Aldrich | Product Number:S0947000 | Purity:EuropeanPharmacopoeia(EP)ReferenceStandard
|
- HGH 191AA(Somatropin）
-
- $70.00/ box
-
2024-05-11
- CAS:12629-01-5
- Min. Order: 2box
- Purity: 99%
- Supply Ability: 100000kg
- HGH 191AA Somatropin
-
- $6.00 / 6iu
-
2023-05-23
- CAS:
- Min. Order: 100iu
- Purity: 99% HPLC
- Supply Ability: 20kg
|
| Product Name: | Somatropin | | Synonyms: | Recombinant human somatotropin;Somatropin (8.63 USP Somatropin Units/vial) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED);SoMatotropin (huMan)(9CI);Growth Hormone from chicken;cb311;crecormon;SOMATOTROPIN (STH), HUMAN PITUITARY, RECOMBINANT, EXPRESSED IN ESCHERICHIA COLI;RecombinantHumanGrowthHormonePowderMateirals/Rhgh | | CAS: | 12629-01-5 | | MF: | C990H1529N263O299S7 | | MW: | 22124.12 | | EINECS: | 235-735-8 | | Product Categories: | Steroid and Hormone;medical intermediate;Human growth hormone;hgh | | Mol File: | Mol File | ![Somatropin Structure]() |
| | Somatropin Chemical Properties |
| alpha | 25 -38.7° (0.1M acetic acid) | | storage temp. | 2-8°C | | form | lyophilized powder | | CAS DataBase Reference | 12629-01-5 |
| Hazard Codes | B | | WGK Germany | 3 | | RTECS | TO7385000 | | HS Code | 2937110000 | | Toxicity | LD50 oral in rat: 160iu/kg |
| | Somatropin Usage And Synthesis |
| Description | Somatropin is a drug that has been approved by the U.S. Food and Drug Administration (FDA) for various uses, though it is mainly used to treat growth disorders in children and growth hormone deficiency in adults. Somatropin is FDA-approved under the brand name Serostim to treat HIV-associated wasting or cachexia in people with HIV. Off-label use of somatropin may include treatment of HIV-associated lipodystrophy syndrome. | | Indications | Somatotropin has approved indications in both the adult and pediatric populations. In the United States, recombinant human growth hormone is used in the pediatric population to treat short stature due to growth hormone deficiency (including idiopathic [of unknown cause] growth hormone deficiency), Turner syndrome, Noonan syndrome, Prader-Willi syndrome, short stature homeobox-containing gene (SHOX) deficiency, chronic renal insufficiency, idiopathic short stature and children small for gestational age. | | Side effects | Common side effects of Somatropin may include:
pain, itching, or skin changes where the medicine was injected;
swelling, rapid weight gain;
muscle or joint pain;
numbness or tingling;
stomach pain, gas;
headache, back pain;
orcold or flu symptoms, stuffy nose, sneezing, sore throat, ear pain. |
| | Somatropin Preparation Products And Raw materials |
|